Emerging Open Models and Concepts of Innovation in the Pharmaceutical Sector
2011 (English)In: Asia Pacific Journal of Innovation and Entrepreneurship, ISSN 2071 - 1395, Vol. 5, no 1, 5-18 p.Article in journal (Refereed) Published
High-tech innovation in a number of emerging and rapidly changing areas such as the pharmaceutical and bio-tech sectors, show signs of a movement from a closed to a more open innovation paradigm. This is primarily due to the possibility of rapid and unlimited communication through the Internet and the www, the increasing global availability of experts, the international reach of the venture capital market, as well as the increasing possibility and interest of external suppliers and interest groups to participate in new product and service development. As a result of this, novel forms of multisource open and user innovation models such as crowd-sourcing and crowd-casting are currently emerging. These new innovation concepts are based on global open innovation and development communities have emerged in several fields of science and business, such as e.g. in the information technologies and bio-medicine. Crowd sourcing and crowd casting are innovation concepts that are based on loosely formed groups of customers, users, scientific communities, or groups of experts who form and collectively shape product or process innovations within a specific innovation field or sector. These open platforms are altering and reforming previously closed innovation concepts to become more open, capable, innovative and cost-effective by using the "wisdom-of-crowds" concept.
This paper describes different formats and potential ways by which emerging open multisource innovation paradigms may alter the pharmaceutical innovation and value creation process in the future. The paper is focusing on how the involvement of a variety of market actors, such as academics, innovators and entrepreneurs, pharmaceutical industry employees, patient advocacy groups, medical professional organizations, hospitals and insurance companies, will influence the common biomedical innovation process and product - market platform. The paper will also introduce a range of new innovation concepts and paradigms by discussing various emerging models of multi-source and open innovator platforms.
Place, publisher, year, edition, pages
AABI , 2011. Vol. 5, no 1, 5-18 p.
Open Innovation, Multiple Communities, User Innovation, Crowd-Sourcing, Crowd-Casting, Biomedicine, Pharmaceutical Industry
Engineering and Technology
IdentifiersURN: urn:nbn:se:liu:diva-74779OAI: oai:DiVA.org:liu-74779DiVA: diva2:492590